...billion and Abbott had sales $20.4 billion. The acquisition is expected to close in 4Q16. St. Jude Medical Inc....

...N.V. by Intrexon Corp. (NYSE:XON) and the 2013 acquisition of medtech play Endosense S.A. by St. Jude Medical Inc....

...did not respond to inquiries (see BioCentury, Sept. 7). Thoratec Corp . (NASDAQ:THOR), Pleasanton, Calif. St. Jude Medical Inc....

...SVP and CSO. Compton was VP and head of translational sciences at Biogen Inc. (NASDAQ:BIIB). St. Jude Medical Inc....

...close next quarter and is subject to Thoratec shareholder approval. Thoratec Corp. (NASDAQ:THOR), Pleasanton, Calif. St. Jude Medical Inc....

...The implantable deep brain stimulation device delivers low intensity electrical pulses to targeted brain areas. St. Jude Medical Inc....

...participated in the €25 million ($36 million) series B round for Endosense S.A. Last year, St. Jude Medical Inc....

...time for publication. Juno Therapeutics Inc. , Seattle, Wash. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland St. Jude Medical Inc....

...president, CEO and a director, formerly president, CEO and chairman of Endosense S.A. , which St. Jude Medical Inc....

...in 2012 sales and declined to provide sales for Endosense. Endosense S.A. , Geneva, Switzerland St. Jude Medical Inc....